Logo image of INUV

INUVO INC (INUV) Stock Fundamental Analysis

NYSEARCA:INUV - US46122W2044 - Common Stock

3.39 USD
+0.02 (+0.59%)
Last: 9/3/2025, 8:24:25 PM
Fundamental Rating

3

Taking everything into account, INUV scores 3 out of 10 in our fundamental rating. INUV was compared to 280 industry peers in the Software industry. The financial health of INUV is average, but there are quite some concerns on its profitability. INUV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year INUV has reported negative net income.
In the past year INUV had a positive cash flow from operations.
In the past 5 years INUV always reported negative net income.
In the past 5 years INUV reported 4 times negative operating cash flow.
INUV Yearly Net Income VS EBIT VS OCF VS FCFINUV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

INUV's Return On Assets of -16.26% is on the low side compared to the rest of the industry. INUV is outperformed by 69.64% of its industry peers.
Looking at the Return On Equity, with a value of -38.61%, INUV is doing worse than 65.00% of the companies in the same industry.
Industry RankSector Rank
ROA -16.26%
ROE -38.61%
ROIC N/A
ROA(3y)-28.94%
ROA(5y)-24.97%
ROE(3y)-54.78%
ROE(5y)-43.28%
ROIC(3y)N/A
ROIC(5y)N/A
INUV Yearly ROA, ROE, ROICINUV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

INUV has a Gross Margin of 81.39%. This is amongst the best in the industry. INUV outperforms 85.00% of its industry peers.
INUV's Gross Margin has improved in the last couple of years.
INUV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.29%
GM growth 5Y6.3%
INUV Yearly Profit, Operating, Gross MarginsINUV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

INUV does not have a ROIC to compare to the WACC, probably because it is not profitable.
INUV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for INUV has been increased compared to 5 years ago.
The debt/assets ratio for INUV has been reduced compared to a year ago.
INUV Yearly Shares OutstandingINUV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
INUV Yearly Total Debt VS Total AssetsINUV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -4.16, we must say that INUV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of INUV (-4.16) is worse than 81.79% of its industry peers.
INUV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.16
ROIC/WACCN/A
WACC11.81%
INUV Yearly LT Debt VS Equity VS FCFINUV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

INUV has a Current Ratio of 0.79. This is a bad value and indicates that INUV is not financially healthy enough and could expect problems in meeting its short term obligations.
INUV's Current ratio of 0.79 is on the low side compared to the rest of the industry. INUV is outperformed by 81.07% of its industry peers.
INUV has a Quick Ratio of 0.79. This is a bad value and indicates that INUV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.79, INUV is doing worse than 80.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.79
INUV Yearly Current Assets VS Current LiabilitesINUV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

INUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
The Revenue has grown by 21.45% in the past year. This is a very strong growth!
INUV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.37% yearly.
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)21.45%
Revenue growth 3Y11.88%
Revenue growth 5Y6.37%
Sales Q2Q%24.5%

3.2 Future

INUV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.57% yearly.
INUV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.18% yearly.
EPS Next Y49%
EPS Next 2Y49.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.25%
Revenue Next 2Y20.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INUV Yearly Revenue VS EstimatesINUV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
INUV Yearly EPS VS EstimatesINUV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

INUV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 35.74, which means the current valuation is very expensive for INUV.
The rest of the industry has a similar Price/Forward Earnings ratio as INUV.
INUV is valuated expensively when we compare the Price/Forward Earnings ratio to 22.48, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 35.74
INUV Price Earnings VS Forward Price EarningsINUV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INUV Per share dataINUV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as INUV's earnings are expected to grow with 49.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.57%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INUV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INUVO INC

NYSEARCA:INUV (9/3/2025, 8:24:25 PM)

3.39

+0.02 (+0.59%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06
Inst Owners18.92%
Inst Owner Change-89.3%
Ins Owners15.01%
Ins Owner Change5.96%
Market Cap49.49M
Analysts84
Price Target12.37 (264.9%)
Short Float %0.99%
Short Ratio0.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.54%
Min EPS beat(2)1.96%
Max EPS beat(2)5.12%
EPS beat(4)4
Avg EPS beat(4)37.07%
Min EPS beat(4)1.96%
Max EPS beat(4)100%
EPS beat(8)7
Avg EPS beat(8)25.64%
EPS beat(12)9
Avg EPS beat(12)11.21%
EPS beat(16)11
Avg EPS beat(16)-2.13%
Revenue beat(2)1
Avg Revenue beat(2)2.1%
Min Revenue beat(2)-6.35%
Max Revenue beat(2)10.56%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-6.35%
Max Revenue beat(4)10.56%
Revenue beat(8)4
Avg Revenue beat(8)3.36%
Revenue beat(12)5
Avg Revenue beat(12)-0.8%
Revenue beat(16)8
Avg Revenue beat(16)1.6%
PT rev (1m)-10.19%
PT rev (3m)766.07%
EPS NQ rev (1m)-266.67%
EPS NQ rev (3m)-833.33%
EPS NY rev (1m)14.27%
EPS NY rev (3m)-1400.38%
Revenue NQ rev (1m)-6.23%
Revenue NQ rev (3m)-20.67%
Revenue NY rev (1m)-3.91%
Revenue NY rev (3m)-2.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 35.74
P/S 0.51
P/FCF N/A
P/OCF 47.36
P/B 4.1
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)0.09
Fwd EY2.8%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.07
OCFY2.11%
SpS6.71
BVpS0.83
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.26%
ROE -38.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.39%
FCFM N/A
ROA(3y)-28.94%
ROA(5y)-24.97%
ROE(3y)-54.78%
ROE(5y)-43.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.29%
GM growth 5Y6.3%
F-Score5
Asset Turnover3.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.6%
Cap/Sales 1.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.79
Altman-Z -4.16
F-Score5
WACC11.81%
ROIC/WACCN/A
Cap/Depr(3y)65.34%
Cap/Depr(5y)55.02%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y49%
EPS Next 2Y49.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.45%
Revenue growth 3Y11.88%
Revenue growth 5Y6.37%
Sales Q2Q%24.5%
Revenue Next Year24.25%
Revenue Next 2Y20.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.21%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y90.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.93%
OCF growth 3YN/A
OCF growth 5YN/A